Even in an era of remarkable therapeutics for neovascular age-related macular degeneration, there remains a lack of therapies ...
Light therapy with multiple wavelengths may safely improve vision, reduce new retinal damage, and improve vision related ...
A clinical-stage biotechnology company developing small-molecule therapies targeting amyloid beta (Aβ) for neurodegenerative ...
Editor’s note: This is an automatically generated transcript, which has been slightly edited for clarity. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription.
Enrollment begins in Switzerland as the company continues to activate clinical sites beyond the U.S. market ANN ARBOR, Mich., March 16, 2026 /PRNewswire/ -- ONL Therapeutics, Inc., a clinical-stage ...
Age-related macular degeneration (AMD) is a leading cause of vision loss among people aged 50 and older. While treatments for the wet form of AMD have shown promise, the dry form, which accounts for ...
PARIS, Jan. 14, 2025 (GLOBE NEWSWIRE) -- PulseSight Therapeutics SAS, an ophthalmology biotech company developing disruptive non-viral vectorized therapies with minimally-invasive delivery technology, ...
Julie Rosenthal, MD, MS, discusses signs and symptoms of age-related macular degeneration as well as methods of treatment. Rosenthal: Some people don't have any symptoms at all when the disease is ...
Share on Pinterest A formulation of over-the-counter antioxidant supplements may help prevent the progression of dry age-related macular degeneration, a new study finds. filmstudio/Getty Images Dry ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results